Analysis of ID2 expression in 145 AML patient BMCs showed that AML patient cells with high levels of ID2 expression were correlated with lower complete remission and shorter overall survival, and was a predictor of poor chemotherapy response (103). The gene discussed is ID2; the disease is acute myeloid leukemia.